Livongo, a company that sells diabetes monitoring technology, on Friday filed paperwork to go public with the US Securities and Exchange Commission. The company most recently had a post-money valuation of $800 million. Livongo is seeking to raise up to $200 million in its IPO and achieve a valuation of $2 billion to $2.5 billion, according to a person familiar with the matter. Click here for more BI Prime stories. Livongo, a company that sells diabetes monitoring technology, just filed to go public. The company on Friday filed paperwork with the US Securities and Exchange Commission to trade on the Nasdaq under the ticker symbol LVGO. Livongo plans to raise up to $200 million in its IPO and achieve a valuation of $2 billion to $2.5 billion, according to a person familiar with the matter. The terms of the offering are subject to change as the IPO draws near. Livongo was founded in 2014 and operates diabetes and other chronic disease management programs using a glucose meter and other devices on behalf of big companies and insurers who pay monthly fees.
Read more
